What does DAYLI Partners invest in?
DAYLI Partners invests most often at Series B (100% of the rounds on record), in sectors such as Bio_healthcare and Finance_governance.

South Korea · Investor
Last cheque observed Feb 2026; 1 cheques on record.
Growth equityDeploying now
Follow DAYLI Partners and see its new cheques in your feed. Start following
1 cheques in the last 12 months
Mostly Series B: 100% of its rounds
DAYLI Partners is a specialized investment group in bio/healthcare & finance/governance.From their own website
Every round we can evidence, newest first1 appearances
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The latest companies DAYLI Partners put money into.
DAYLI Partners invests most often at Series B (100% of the rounds on record), in sectors such as Bio_healthcare and Finance_governance.
1 investments on record, 1 of them in the last 12 months. The most recent was in Feb 2026.
Its most recent investments on record: Galux (Series B, Feb 2026).
The median round it joins is $29M.
Yes: it is actively investing, with 1 investments in the last 12 months.
DAYLI Partners is a growth equity firm based in Seoul, South Korea.
From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it